• About us
• Contact

Advertisement

Organisation › Details

Sofinnova Partners SAS

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London, and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical, and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact our collective future. Founded in 1972, Sofinnova Partners is deeply established in Europe, with 50 years of experience backing over 500 companies and creating market leaders around the globe. Today, Sofinnova Partners manages over €4 billion in assets. *

 

	Start	1997-08-25 established
	Group	Sofinnova (Group)
	Industry	venture capital
	Industry 2	LIFE SCIENCES
	Person	Papiernik, Antoine (Sofinnova Partners 201703 Managing Partner + Chairman joined 1997)
	Person 2	Lucquin, Denis (Sofinnova Partners 201509 Managing Partner + Chairman)
	Region	Paris
	Country	France
	Street	7–11 Boulevard Haussmann
	City	75009 Paris
	Tel	+33-1-7623-4100
		Address record changed: 2024-01-05
Basic data	Employees	C: 51 to 100 (2025-03-04)
	Currency	EUR
	Annual sales	4,000,000,000 (assets under management (2025) 2025-03-04)
		* Document for »About Section«: Sofinnova Partners. (3/4/25). "Press Release: Sofinnova Partners Raises €1.2 Billion to Fuel the Next Wave of Life Sciences Innovation". Paris.
		Record changed: 2025-03-05

Advertisement

More documents for Sofinnova (Group)

• [1] Purespring Therapeutics Ltd.. (10/9/24). "Press Release: Purespring Therapeutics Raises £80/$105 Million in a Series B Financing to Transform the Treatment of Kidney Diseases". London....
• [2] Genespire S.r.l.. (9/25/24). "Press Release: Genespire Raises €46.6 Million (~$52 Million) in a Series B Round to Advance Its First Pediatric in-vivo Gene Therapy into the Clinic". Milan....
• [3] Novameat Tech SL. (9/12/24). "Press Release: Novameat Raises €17.4M Oversubscribed Series A Round Led by Sofinnova Partners and Forbion". Barcelona....
• [4] Sofinnova Partners. (9/10/24). "Press Release: Sofinnova Partners Appoints Karl Naegler as Partner". Paris....
• [5] Deepc GmbH. (7/24/24). "Press Release: Deepc Closes Series A Extension to Accelerate Global Deployment of Healthcare AI, Bringing Total Funding to $30m". Munich....
• [6] Endoron Medical Ltd.. (7/9/24). "Press Release: Endoron Medical Raises $10 Million in Series A Funding Led by Sofinnova Partners to Accelerate the Validation of Its AAA EndoStapling Solution Aortoseal". Tel Aviv....
• [7] Cure51 SAS. (3/20/24). "Press Release: Cure51 Raises a €15 Million Seed Round to Harness the Natural Power of Cancer Survivors to Develop First-in-Class Treatments and Transform Cancer into a Curable Disease". Paris....
• [8] Bioptimus SAS. (2/20/24). "Press Release: Ex-Google DeepMind and Owkin Scientists Team up to Create Bioptimus to Build the First Universal AI Foundation Model for Biology"....
• [9] GenSight Biologics S.A.. (2/8/24). "Press Release: GenSight Biologics Announces Completion of a €5 million capital Increase with Sofinnova Partners, Invus, UPMC Enterprises and Heights Capital". Paris....
• [10] Disco Pharmaceuticals GmbH. (1/16/24). "Press Release: Disco Pharmaceuticals Launches as the Surfaceome Company with EUR 20 Million in Seed Financing". Cologne & Zurich....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.